Literature DB >> 8446055

Effect of hyperglycemia per se on glucose turnover rates in patients with insulin-dependent diabetes.

O Hother-Nielsen1, A Vaag, P Skøtt, H Beck-Nielsen.   

Abstract

The effect of hyperglycemia, per se, on glucose utilization and hepatic glucose production was reevaluated in eight C-peptide-negative insulin-dependent diabetic patients using primed-continuous noncontaminated 3-3H-glucose infusion and labeled glucose infusates. The night before study, euglycemia was maintained by a variable insulin infusion. During the studies, insulin was infused at basal replacement rates determined as the rate required to maintain euglycemia in the morning. After a 2-hour equilibration period, either plasma glucose level was increased to 12 mmol/L for 4 hours using a variable glucose infusion, or no glucose was infused (control day). On the hyperglycemic day, glucose utilization increased 16% (86 +/- 2 to 99 +/- 4 mg.m-2.min-1, P < .02) and glucose production decreased 45% (85 +/- 3 to 47 +/- 4 mg.m-2.min-1, P < .01). On the control day, both glucose utilization and glucose production decreased (84 +/- 3 to 68 +/- 3 and 84 +/- 3 to 65 +/- 3 mg.m-2.min-1, respectively; both P < .01). Therefore, comparing rates at the end of the hyperglycemic and control studies, glucose utilization was increased by 45% and glucose production was decreased by 28% in response to hyperglycemia (both P < .01). Thus hyperglycemia, at basal insulin levels enhanced glucose utilization and suppressed glucose production in insulin-dependent diabetic patients. Quantitatively, the enhancement of glucose utilization was more important than the suppressive effect on glucose production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446055     DOI: 10.1016/0026-0495(93)90177-p

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.

Authors:  J R Zierath; L He; A Gumà; E Odegoard Wahlström; A Klip; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

2.  Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Authors:  A Vaag; F Alford; F L Henriksen; M Christopher; H Beck-Nielsen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

3.  Direct and indirect effects of amino acids on hepatic glucose metabolism in humans.

Authors:  M Krebs; A Brehm; M Krssak; C Anderwald; E Bernroider; P Nowotny; E Roth; V Chandramouli; B R Landau; W Waldhäusl; M Roden
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

4.  Skeletal muscle phosphodiester content relates to body mass and glycemic control.

Authors:  Julia Szendroedi; Albrecht Ingo Schmid; Marek Chmelik; Martin Krssak; Peter Nowotny; Thomas Prikoszovich; Alexandra Kautzky-Willer; Michael Wolzt; Werner Waldhäusl; Michael Roden
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

5.  Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.

Authors:  Julia Szendroedi; Albrecht I Schmid; Marek Chmelik; Christian Toth; Attila Brehm; Martin Krssak; Peter Nowotny; Michael Wolzt; Werner Waldhausl; Michael Roden
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.